Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caplan, S.
Right arrow Articles by Baniyash, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caplan, S.
Right arrow Articles by Baniyash, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 34, Issue of August 23, 1996 pp. 20705-20712
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Normal T Cells Express Two T Cell Antigen Receptor Populations, One of Which Is Linked to the Cytoskeleton via zeta  Chain and Displays a Unique Activation-dependent Phosphorylation Pattern*

(Received for publication, March 5, 1996)

Steve Caplan and Michal Baniyash Dagger

From The Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The TCR couples antigen recognition and the transmission of activation signals. We report the expression of two TCR populations on the surface of T lymphocytes, one of which is linked to the cytoskeleton via the zeta  chain. We also demonstrate that assembly of the CD3 subunits with cytoskeleton-associated zeta  is necessary for their maximal localization to the cytoskeleton. The potential significance of these two receptor forms is underscored by differences observed in non-activated T cells; while detergent-soluble phosphorylated zeta  appears as a 21-kDa protein, phosphorylated cytoskeleton-associated zeta  appears as a 16-kDa form. This dichotomous phosphorylation pattern is rigidly maintained following activation, although each of the receptor populations undergoes different activation-dependent modifications: 1) levels of soluble phosphorylated 21-kDa zeta  are enhanced, while phosphorylated 16-kDa cytoskeleton-associated zeta  exhibits little change; 2) soluble non-phosphorylated 16-kDa zeta  translocates to the cytoskeleton; 3) activation-dependent ubiquitinated zeta  forms localize to both fractions, albeit with different kinetics. We also show that the protein tyrosine kinase Lck undergoes activation-dependent modifications and translocates to the cytoskeleton. The phosphorylation profiles of the dichotomous TCR populations in both non-activated and activated lymphocytes suggest that each population could regulate distinct cellular functions, possibly by select intermolecular associations.


INTRODUCTION

The TCR1 is a multisubunit complex composed of the clonotypic alpha /beta disulfide-linked heterodimer and the invariant disulfide-linked zeta /zeta and/or zeta /eta dimers (1). While the alpha /beta heterodimers are involved in antigen-major histocompatibility complex recognition and binding, the invariant chains couple antigen recognition to various intracellular signal transduction pathways (1, 2). Cumulative evidence from various studies indicates that of the invariant chains, zeta  plays a key role in the transmission of activation signals in the process of T cell stimulation (3, 4, 5, 6).

None of the TCR subunits possess intrinsic kinase activity, therefore association of the invariant subunits with various intracellular molecules appears to be crucial for mediating the signaling process. Little is known about such associations in non-activated T cells. Thus far, only the protein tyrosine kinase Fyn has been found to maintain a constitutive association with the non-phosphorylated zeta  chain in non-activated T cells (7, 8). However, recent reports (9, 10) have shown that freshly isolated, non-activated thymocytes and lymph node T cells express a basal level of tyrosine-phosphorylated zeta  chain, to which the ZAP-70 protein tyrosine kinase is constitutively associated in a phosphorylation dependent manner. Following TCR cross-ligation, Src family tyrosine kinases Fyn and Lck are activated, promoting augmented tyrosine phosphorylation of the zeta  and epsilon  subunits and enhanced recruitment of ZAP-70. The latter is then phosphorylated by the Src family tyrosine kinases, culminating in its activation. In vitro studies have shown that the phosphorylated zeta  chain can also interact with adapter proteins such as Shc (11) and/or Grb2 (12), resulting in coupling of the TCR to the Ras signaling pathway. It remains to be determined whether additional intracellular molecules interact with the TCR invariant subunits and what role(s) such interactions play, particularly in non-activated T cells.

We have previously shown that 10-40% of the TCR zeta  chains are linked to the cytoskeleton in non-activated T cells, and that this linkage is dependent upon the integrity of the actin microfilament system (13). A recent study by Rozdzial et al. (14) supports our findings and shows that zeta  chain can be co-immunoprecipitated with actin. The potential significance of the association of various cell surface receptors with the cytoskeleton is reflected by a number of recent studies (reviewed in Ref. 15). Such associations have been observed for the following cell surface-expressed molecules: epidermal growth factor receptors (16, 17), integrin receptors (18), CD2 (19), the tyrosine phosphatase CD45 (20), the B cell antigen receptor (21, 22, 23, 24), and the high affinity receptor for immunoglobulin E (Fcepsilon R1) (25, 26, 27). However, the physiologic relevance of most of these interactions is at present unclear.

In the current study we extend our understanding of the interactions between zeta  chain, the CD3 gamma , delta , and epsilon  subunits and the cytoskeletal matrix in non-activated T cells. We demonstrate that cytoskeleton-associated zeta  (cska-zeta ) chain is assembled within a complex containing the TCR subunits in normal mouse lymphocytes. Furthermore, we have shown in this study that the localization of CD3 to the Triton-insoluble fraction is largely dependent on the presence of the cska-zeta chain. Our results suggest that there are two cell surface-expressed TCR populations: Triton-soluble receptors and Triton-insoluble receptors, of which only the latter are linked to the cytoskeleton via the TCR zeta  chain. We demonstrate that in non-activated mouse lymphocytes, the Triton-insoluble cska-zeta chain differs from its Triton-soluble counterpart in its phosphorylation state and possibly also in its conformation. While these differentially phosphorylated zeta  forms are maintained in their respective fractions subsequent to TCR-mediated triggering, we have established that various ubiquitinated phosphorylated forms are common to both soluble and cytoskeletal fractions, albeit with different kinetics. Finally, we provide data showing that Lck, a key protein tyrosine kinase involved in TCR-mediated signaling, displays a cytoskeletal localization which is dependent on the state of cellular activation. These results suggest that the cska-zeta form could play a unique role in mediating signal transduction events initiated by receptor cross-ligation and transmitted via the cytoskeleton. The outcome of cytoskeletal involvement could result either in T cell activation, or alternatively serve to negatively regulate signals transmitted via the TCR by inducing anergy and/or cell death. The zeta -cytoskeleton linkage may also affect receptor stability, and events such as internalization and/or recycling, processes which occur in both non-activated and activated T cells.


EXPERIMENTAL PROCEDURES

Animals

BALB/c female mice were bred in our SPF facility.

Cells and Antibodies

Thymocytes were isolated from mice aged 4 weeks and splenocytes were derived from mice aged 12-16 weeks. The antigen-specific T-cell hybridoma 2B4 and zeta -deficient T-cell hybridomas 5.8 were grown as described (28). The 145-2C11 (2C11) hamster monoclonal antibody is directed against the murine CD3epsilon chain (29). Anti-CD3-delta and anti-zeta polyclonal antibodies were generated in rabbits as described (30, 31). Anti-CD3gamma and anti-CD3epsilon polyclonal antibodies were generated in rabbits immunized with denatured protein eluted from SDS-PAGE. The monoclonal anti-phosphotyrosine antibody 4G10 was obtained from Upstate Biotechnology (Lake Placid, NY). Immunoprecipitations were done using antibodies bound to protein A-Sepharose beads (Pharmacia).

Cell-surface Labeling

Cells were radiolabeled with Na125I by lactoperoxidase as described previously (13). For biotinylation, cells (1 × 108) were resuspended in a buffer (pH 8.8) containing 10 mM sodium borate, 150 mM NaCl, and 50 µg/ml D-biotinyl-epsilon -amidocaproic acid N-hydroxysuccinimide ester (biotin-ester) (Boehringer Mannheim) for 45 min at 22 °C. The reaction was terminated by the addition of 10 mM ammonium chloride and cells were washed 3 times at 4 °C with phosphate-buffered saline.

zeta Chain Constructs and Transfection of zeta -Deficient T Cells

The full-length murine zeta  cDNA construct has been previously described (32). The cDNA was inserted into the PCDLSRalpha expression vector that contains the simian virus 40 promoter (33). The expression vector was provided by Stuart Frank (University of Alabama, Birmingham). The Taczeta zeta construct encodes for a fusion protein composed of the extracellular domain of the IL-2 receptor alpha  chain, the transmembrane and intracytoplasmic domains of zeta  chain (34) and was provided by Francois Letourneur (Basel Institute for Immunology, Switzerland). 5.8 cells (1 × 107) were suspended in 2 ml of RPMI containing 30 µg/ml DEAE-dextran and transfected with 10 µg of cDNA. Cells were then incubated at 37 °C for 45 min, washed three times, incubated for a further 42 h and harvested.

Activation of Mature Mouse Lymphocytes

To minimize the level of basal activation, splenocytes were isolated and ``rested'' by incubation at 37 °C overnight in RPMI supplemented with 8% fetal calf serum. These non-activated splenocytes were harvested, washed, and incubated at 37 °C with continuous shaking for the indicated times in the presence of 2C11 ascites (1:250). No additional cross-linking antibodies were necessary since the splenocyte population amply provided the natural antigen presenting cells. The activation was terminated by cooling the cells to 4 °C and diluting the samples with Hanks' balanced salt solution containing phosphatase inhibitors. Cells were washed 3 times prior to lysis.

Cell Lysis and Separation of Detergent-soluble and -insoluble Fractions

Cell pellets were lysed either as described previously (13) or by using modified lysis buffer containing 0.5% Triton X-100, 50 mM MES (pH 6.9), 10 µg/ml both aprotonin and leupeptin, 1 mM phenylmethylsulfonyl fluoride, 1.8 mg/ml iodoacetamide and phosphatase inhibitors. Cell pellets were lysed for 15 min on ice with gentle mixing and centrifuged (15,000 rpm) for 10 min at 4 °C. The supernatant was designated as the soluble fraction, and the insoluble pellet was washed for 3 min in the same lysis buffer and centrifuged again under the same conditions. The washed pellet was designated as the insoluble fraction. For analysis of the total insoluble fraction, proteins were extracted by mechanical agitation and incubated for 20 min at 95 °C in sample buffer containing 4% SDS. For immunoprecipitations of proteins from the insoluble fraction, Triton-insoluble pellets were suspended in 200 µl of buffer containing 30 mM NaCl, 5 mM MgCl2, protease inhibitors, 20 units of DNase I (Boehringer Mannheim) and incubated at 22 °C for 45 min. The solubilized proteins extracted from the Triton-insoluble pellet were obtained in the supernatant after centrifugation.

Immunoprecipitation, Electrophoresis, Immunoblotting, and Scanning Densitometry

Immunoprecipitations of the soluble fractions were performed as described (13). For immunoprecipitation of proteins in the Triton-insoluble fraction, solubilized proteins from the Triton-insoluble fraction were obtained after treatment with DNase I, equilibrated to 150 mM NaCl, and immunoprecipitated for 3 h at 4 °C. Samples were separated on two-dimensional non-reducing/reducing SDS-PAGE and transferred onto nitrocellulose filters as described (3, 4). For radiolabeled samples, filters were exposed to x-ray films and later incubated with specific antibodies. Proteins were detected with either anti-mouse immunoglobulin horseradish peroxidase conjugate or protein A-horseradish peroxidase conjugate. Biotinylated proteins were detected by adding streptavidin-conjugated horseradish peroxidase. Visualization was achieved using enhanced chemiluminescence (Amersham). Scanning densitometry was done with the Bio-Rad Molecular Analyst System (Hercules, CA) on multiple exposures to ensure linearity and accuracy of the results.


RESULTS

Cska-zeta Chain Forms a Complex with the CD3 gamma , delta , and epsilon  Subunits Which Is Expressed on the Cell Surface of Non-activated Normal Lymphocytes

An important issue concerning the putative function of cska-zeta chain in non-activated lymphocytes is whether it assembles with the TCR complex or is expressed on the cell surface independently of the remainder of the TCR subunits. Thus, we first determined whether any of the CD3 subunits could be detected in the detergent-insoluble cytoskeletal fraction, together with the cska-zeta chain. Accordingly, we utilized a detergent-based lysis solution containing the cytoskeleton-preserving buffer MES to minimize dissociation of loosely bound cytoskeleton-associated molecules (Refs. 35 and 36; see also ``Experimental Procedures''). Upon lysis of freshly isolated thymocytes, the TCR zeta  chain was detected in both the Triton-soluble and Triton-insoluble fractions (Fig. 1A). Increasing the lysis time or temperature from 4 to 22 °C (data not shown) had no effect on the level of zeta  chain in each fraction; 30-40% of the zeta  chain was Triton-insoluble and 60-70% was Triton-soluble. Analysis of CD3 subunit localization under similar conditions revealed that there is a hierarchy for the association of the TCR subunits with the cytoskeleton (Fig. 1A). While the highest Triton-insoluble to Triton-soluble protein ratio (I/S ratio) is maintained by the zeta  chain, the CD3 gamma  and delta  chains can also be detected in the Triton-insoluble cytoskeletal fraction. The CD3 epsilon  chain also appears to be weakly associated with the cytoskeleton and has the lowest I/S ratio. Similar results were also obtained following the analysis of mouse splenocytes (data not shown).


Fig. 1. A, differential localization of the TCR invariant subunits to the detergent-insoluble cytoskeleton. Freshly isolated thymocytes were lysed in the modified MES-lysis buffer (see ``Experimental Procedures''); Triton-soluble (SOL) (2.5 × 107 cells) and Triton-insoluble (INS) (5 × 107 cells) fractions were denatured and separated by two-dimensional non-reducing/reducing SDS-PAGE. After transfer to nitrocellulose filters, the filters were incubated with polyclonal anti-zeta , anti-delta , and anti-gamma epsilon antibodies and proteins were detected (see ``Experimental Procedures''). To visualize the TCR subunits simultaneously, autoradiograms were superimposed. B, the detergent-insoluble CD3 subunits are associated with the cska-zeta chain in normal lymphocytes. Freshly isolated mouse thymocytes were cell surface biotinylated (see ``Experimental Procedures''). Labeled cells were lysed with MES-lysis buffer and Triton-soluble (SOL) and insoluble (INS) fractions were obtained. These samples were immunoprecipitated with anti-zeta antibodies, separated by two-dimensional non-reducing/reducing SDS-PAGE, and transferred to nitrocellulose filters. Streptavidin-horseradish peroxidase and enhanced chemiluminescence were used to detect biotinylated proteins on the filters.
[View Larger Version of this Image (72K GIF file)]

We next analyzed whether cell surface-expressed cska-zeta chain is associated with the Triton-insoluble CD3 (gamma , delta , and epsilon ) subunits and is part of the TCR complex. For this purpose, we performed immunoprecipitations of the Triton-insoluble and Triton-soluble fractions of freshly isolated thymocytes following cell-surface labeling with biotin-ester (Fig. 1B). To retain potential associations between non-covalently linked proteins in the Triton-insoluble cytoskeletal fraction, we extracted the proteins in the Triton-insoluble pellets with DNase I, and avoided the use of denaturing agents. This enzyme digests the DNA in the nuclei which are localized to the Triton-insoluble fraction and also induces in vitro depolymerization of the actin microfilaments (37). Following this procedure, anti-zeta antibodies clearly immunoprecipitated not only surface labeled zeta  chain, but also the CD3 gamma , delta , and epsilon  subunits (Fig. 1B) as well as the Ti alpha  and beta  chains (data not shown). Although the relative level of Triton-insoluble zeta  chain is greater than that of the CD3 subunits, when biotinylated, the latter appear to have a greater representation in the Triton-insoluble fraction. This discrepancy arises from the fact that the CD3 subunits possess large extracellular domains with 4-9 lysine residues (targets for biotinylation) as opposed to a single lysine residue in the short extracellular domain of zeta  chain. Although we cannot rule out the possibility that some of the cell surface-expressed cska-zeta chain is expressed independently of the TCR complex, the analysis of immunoprecipitates derived using anti-zeta (Fig. 1B) and anti-delta (data not shown) antibodies clearly demonstrates that cska-zeta chain is physically associated with Triton-insoluble CD3 gamma , delta , and epsilon  subunits. These results reveal that there are two TCR populations expressed on the cell surface of non-activated T cells; one is linked to the cytoskeleton while the other is detergent-soluble and not associated with the cytoskeleton.

Localization of CD3 gamma , delta , and epsilon  Subunits to the Triton-insoluble Fraction Is Enhanced Upon Their Association with Cska-zeta

To determine whether the localization of the CD3 subunits to the Triton-insoluble fraction depends upon the expression of cska-zeta chain, we examined the levels of Triton-insoluble CD3 chains in the 5.8 zeta -deficient T cell hybridomas. Although 5.8 cells do not express the zeta  chain, they synthesize the remaining TCR subunits, most of which are degraded in the lysosome with a small portion of zeta -deficient TCR expressed on the cell surface (38). Scanning densitometric analysis consistently showed that upon lysis of 5.8 cells, relatively low levels of the CD3 subunits were retained in the Triton-insoluble fraction. The CD3 I/S ratio in 5.8 cells was 3-5-fold lower than that of the parental 2B4 hybridoma cells, which express the zeta  chain and both the detergent-soluble and cytoskeleton-linked TCR populations (Table I). To assess whether the expression of zeta  chain affects the Triton-insolubility of CD3, we transiently transfected 5.8 cells with full-length zeta  cDNA. Fluorescence-activated cell sorter analysis demonstrated that following transfection, TCR cell-surface expression was reconstituted (data not shown) and the transfectants displayed an I/S ratio for zeta  chain similar to that observed with the parental 2B4 cells (Table I). Accordingly, we also found a 2-3-fold increase in the I/S ratio of CD3 gamma  and delta . Although the relative levels of Triton-insoluble gamma  and delta  in the transfected cells were increased, they did not reach those of 2B4, likely due to the low transfection efficiency. In order to determine whether the anchorage of CD3 to the cytoskeleton depends only upon the expression of cska-zeta , or whether it also requires correct assembly with cska-zeta , we also transfected 5.8 cells with a Taczeta zeta construct (see ``Experimental Procedures''). Taczeta zeta is a chimeric molecule which is expressed on the cell surface independently of the rest of the TCR chains and does not ``drag'' them to the cell surface (34). We demonstrate here that while surface-expressed Taczeta zeta was found both in the Triton-insoluble cytoskeletal fraction and the Triton-soluble fraction, it did not reconstitute the levels of Triton-insoluble CD3 (Table I) and was unable to invoke TCR cell surface expression (data not shown). This is in contrast to what was observed following transfections with full-length zeta  chain cDNA. Consequently, the assembly of cska-zeta chain with the CD3 subunits appears necessary for optimal Triton-insoluble CD3 localization and the CD3-cytoskeleton association appears to be mediated via the cska-zeta chain.

Table I.

Comparison of the Triton X-100 insoluble/soluble ratio of the invariant TCR subunits in various cell lines

Cska-zeta is required for optimal localization of CD3 gamma , delta , and epsilon  subunits to the Triton-insoluble cytoskeleton. The parent 2B4 hybridoma cell line, zeta -deficient 5.8 cells (5.8), and zeta -deficient 5.8 cells transfected with either the full-length zeta  cDNA (5.8/FLzeta ) or the Taczeta zeta construct (5.8/Taczeta zeta ) were lysed, separated to Triton-soluble and insoluble fractions, and resolved by two-dimensional non-reducing/reducing SDS-PAGE. Western blot analysis was used to determine the I/S ratios of the TCR invariant chains. Quantitative densitometric analysis was performed on multiple film exposures using the Bio-rad Molecular Analyst System. The results presented as I/S ratios are representative of a series of five independent experiments.
Cell line TCR subunit
 zeta  delta  gamma  epsilon

2B4 0.670 0.380 0.310 NDa
5.8 0.075 0.075 ND 
5.8/FLzeta 0.500 0.220 0.220 ND 
5.8/Taczeta zeta 0.430-0.700b 0.083 0.081 ND 

a  ND, not done.
b  The Taczeta zeta I/S ratio is presented as a range due to the wide variation of the glycosylated forms.

The Two TCR Populations in Non-activated T cells Possess Distinct Forms of zeta  Chain

The results demonstrating that there are two TCR populations, one of which is linked to the cytoskeleton via zeta  chain, raised the issue of whether the zeta  chains associated with each population exhibit any differences. Our earlier studies (13) have demonstrated that following cell surface iodination using lactoperoxidase, cska-zeta chain was preferentially labeled while only trace levels of iodinated soluble zeta  chain were detected. It was unclear at that time whether only the cska-zeta chain resides on the cell surface, or whether both forms are cell surface-expressed but differentially iodinated due to specific structural differences. To resolve this issue, we compared the labeling of the two zeta  forms by using two different labeling methods, iodination and biotinylation. While the former targets tyrosine residues, the latter binds to the free epsilon amino groups, such as those on lysine residues. As shown in Fig. 2, A-D, cell surface iodination of freshly isolated thymocytes using lactoperoxidase labels cska-zeta chain (A) but does not yield detectable levels of labeled soluble zeta  chain (A). However, cell surface labeling with biotin-ester allows detection of both zeta  forms (C), albeit with a preference for the cska-zeta form. To verify that only cell surface-expressed molecules are labeled by these two procedures, we immunoprecipitated Lck, which is associated with the inner leaflet of the membrane via a myristoyl group and, as such, represents an exclusively cytosolic membrane-bound molecule. Since Lck could not be detected following either iodination or biotinylation (data not shown), it appears unlikely that intracellular molecules were labeled by these procedures. Thus, both Triton-insoluble and soluble zeta  chains are expressed on the cell surface, but differ in their ability to be surface iodinated.


Fig. 2. A-D, both soluble and cska-zeta chains are cell surface-labeled by biotinylation, but cska-zeta is preferentially labeled by iodination. Freshly isolated mouse thymocytes were subjected to cell surface labeling by either iodination or biotinylation (see ``Experimental Procedures''). Cells were lysed, relegated to detergent-soluble (SOL), and insoluble (INS) fractions and separated by two-dimensional non-reducing/reducing SDS-PAGE. After transfer to nitrocellulose, filters containing radiolabeled proteins were exposed to x-ray films (A). Filters containing biotinylated proteins were treated with streptavidin-horseradish peroxidase and subjected to enhanced chemiluminescence (C). The filters containing labeled proteins from the two labeling procedures were later incubated with anti-zeta antibodies and proteins were detected (B and D) as described. E and F, in non-activated thymocytes, the tyrosine-phosphorylated 21-kDa zeta  form is exclusively localized to the detergent-soluble fraction while the phosphorylated 16-kDa zeta  form is retained only in the detergent-insoluble cytoskeletal fraction. Freshly isolated mouse thymocytes were lysed with the MES lysis buffer. Detergent-soluble and insoluble fractions were obtained and separated by two-dimensional non-reducing/reducing SDS-PAGE and Western blotting was performed. The nitrocellulose filters were incubated with either anti-zeta antibodies (E) or anti-phosphotyrosine antibodies (F). Proteins were detected using either protein A-horseradish peroxidase (E) or goat anti-mouse-horseradish peroxidase (F) and enhanced chemiluminescence.
[View Larger Version of this Image (43K GIF file)]

An additional difference between the two TCR populations which may well have physiologic ramifications is the phosphorylation state of each of the zeta  forms. Indeed, the possibility of such a dichotomous phosphorylation pattern was raised in our previous study (13) which demonstrated that one of the hallmarks of cska-zeta chain is that a certain level is constitutively phosphorylated in non-activated T cells, yet despite this displays the same molecular mass as its soluble non-phosphorylated 16-kDa counterpart. Various biochemical studies analyzing the state of zeta  phosphorylation in freshly isolated young lymphocytes have concentrated only on detergent-soluble fractions, and have shown that in this fraction there is a basal level of 21-kDa tyrosine-phosphorylated zeta  chain (9, 10). In order to assess whether the 21-kDa form is also localized to the detergent-insoluble fraction, we used thymocytes isolated from 4-week-old mice, which often have basal levels of this form. The results shown in Fig. 2, E and F, demonstrate that contrary to the phosphorylated 16-kDa zeta  form localized solely to the cytoskeletal fraction, the 21-kDa phosphorylated form was detected only in the detergent soluble fraction. Similar results were obtained with freshly isolated splenocytes (data not shown). Even after ``resting'' the lymphocytes by incubation overnight at 37 °C, no 21-kDa phosphorylated zeta  could be detected in the detergent-insoluble fraction despite the dramatic decrease in the level of this form in the detergent-soluble fraction (see Fig. 3A). Such differences observed in non-activated T cells suggest putative distinct associations with intracellular molecules even prior to activation, which in turn may affect cellular functions upon antigen binding.


Fig. 3. TCR-mediated stimulation of normal mouse splenocytes induces activation-dependent modifications in zeta  (A) and epsilon  (B) TCR subunits. Mouse splenocytes were activated with 2C11 ascites (1:250) for the indicated times after resting overnight and lysed with MES lysis buffer. After separation to Triton-soluble (SOL) and insoluble (INS) fractions, samples (SOL, 5 × 107 cells; and INS, 1 × 108 cells) were subjected to two-dimensional non-reducing/reducing SDS-PAGE (12-13%) and transferred to nitrocellulose filters. Filters were incubated with anti-zeta antibodies (A), anti-epsilon antibodies (B), or anti-phosphotyrosine antibodies (anti-pTyr, A and B) followed by incubation with protein A-horseradish peroxidase (for anti-zeta and anti-epsilon ) or goat anti-mouse horseradish peroxidase (for anti-phosphotyrosine). Protein detection was performed as described. Open arrow indicates the position of the soluble 21-kDa phosphorylated zeta  form, and filled arrow indicates the position of the 16-kDa zeta  form in both fractions.
[View Larger Version of this Image (45K GIF file)]

Distinct Activation-dependent Modifications of the Detergent-soluble and Cytoskeleton-associated TCR Populations

To examine the putative function of the cytoskeleton-associated TCR population, and its possible involvement in early receptor-mediated signaling events, we studied the kinetics of activation-dependent changes for each of the receptor populations. For this purpose, we activated normal mouse splenocytes for various time intervals with anti-CD3 antibodies cross-linked by antigen presenting cells also derived from the splenic population. As indicated in Fig. 3A, within 5 min of stimulation, there was a dramatic increase in the level of 21-kDa phosphorylated zeta  chain, indicative of TCR-mediated activation. However, even after 30 min of stimulation, the 21-kDa phosphorylated zeta  form was localized exclusively to the Triton-soluble fraction and was never observed in association with the cytoskeleton. In contrast, the 16-kDa phosphorylated form remained unique to the cytoskeletal fraction, even after 30 min of stimulation (Fig. 3A). Moreover, the phosphorylated 16-kDa cska-zeta form was not enhanced upon TCR-mediated activation, and in several experiments a slight activation-dependent decrease was observed after 15-30 min of activation. Despite little change in the level of 16-kDa phosphorylated cska-zeta form, the total protein level of cska-zeta (detected with anti-zeta antibodies) showed an activation-dependent increase which generally peaked between 15 and 30 min (Fig. 3A). Under these conditions, a slight decrease in Triton-soluble non-phosphorylated 16-kDa zeta  was observed. Differences were also observed in the CD3 epsilon  chains of the two receptor populations. Despite an activation-induced increase in the level of tyrosine phosphorylation of soluble epsilon  chains and changes in migration using two-dimensional non-reducing/reducing SDS-PAGE (Fig. 3B), only trace amounts of epsilon  could be detected in the detergent-insoluble cytoskeletal fraction both prior to and after activation (data not shown). Even after 30 min of stimulation, no phosphorylated or unphosphorylated epsilon  could be detected in the cytoskeletal fraction.

In the process of studying early activation-dependent modifications of the two receptor populations, we analyzed the ubiquitination state of soluble and cska-zeta . Cenciarelli et al. (39) have previously reported that TCR-triggering induces ubiquitination of zeta  chain, but in this study only the Triton-soluble fraction was analyzed. Therefore, we determined whether ubiquitinated zeta  forms could also be detected in the Triton-insoluble cytoskeletal fraction. In these experiments splenocytes were stimulated as described above and the presence of zeta  chain in the various fractions was analyzed. While the level of detergent-soluble ubiquitinated zeta  forms reached a peak after about 30 min of stimulation, the level of ubiquitinated cska-zeta forms showed a dramatic increase which peaked within 5 min of stimulation (Fig. 4A). Moreover, both the 24-kDa ubiquitinated cska-zeta and soluble zeta  forms were phosphorylated (Fig. 4B), with peak phosphorylation levels appearing within 5 min of activation for both forms. However, the level of phosphorylation of the 24-kDa cska-zeta form was consistently higher than its soluble counterpart. Maintenance of the dichotomy of phosphorylated soluble and cska-zeta forms even after activation, together with the differences in kinetics shown here, suggest that each of the two TCR populations may play select roles in receptor-mediated activation events.


Fig. 4. Distinct activation-dependent ubiquitination kinetics of the detergent-soluble and cska-zeta forms. Mouse splenocytes were treated and processed as described in the legend to Fig. 3. Soluble (SOL) and insoluble (INS) samples (5 × 107 cells each) were subjected to two-dimensional non-reducing/reducing SDS-PAGE, transferred to nitrocellulose filters, and incubated with anti-zeta antibodies (A) or anti-phosphotyrosine antibodies (B). Proteins were detected as described. I, indicates the position of the 24-kDa mono-ubiquitinated zeta  form. II, indicates the position of the 32-kDa ubiquitinated zeta  form. III, indicates the position of the 40-kDa ubiquitinated zeta  form.
[View Larger Version of this Image (50K GIF file)]

TCR-mediated Activation of Normal Splenocytes Induces Changes in the Detergent-solubility of Lck

The activation-dependent kinetics and differences observed in the phosphorylation patterns of detergent soluble and cska-zeta chains strongly suggest that the cytoskeleton-associated TCR population may be involved in early signaling events. Therefore, we determined whether additional molecules which are known to play a role in early TCR-mediated signaling events are also modified upon TCR triggering and localize to the detergent-insoluble cytoskeletal fraction. In these experiments, we performed a kinetic analysis to assess the detergent-insoluble cytoskeletal localization of Lck upon T cell activation. Our results show that in non-activated splenocytes, two forms of Lck could be detected; the 56-kDa form present primarily in the detergent-soluble fraction and a 60-kDa Lck form localized mainly to the detergent-insoluble fraction. The two Lck forms were detected by immunoblotting of total lysates (Fig. 5), or of immunoprecipitated samples (data not shown). Subsequent to 1 min of TCR triggering, the detergent-insoluble 60-kDa Lck form was no longer detected and after 5 min of activation this 60-kDa form was also absent in the detergent-soluble fraction (Fig. 5). However, after 30 min of activation we observed a reappearance of the 60-kDa Lck form, in both the detergent-soluble and detergent-insoluble cytoskeletal fractions. While the 60-kDa Lck form is localized to both soluble and insoluble fractions with specific activation-dependent kinetics, the 56-kDa Lck form localizes only to the detergent-soluble fraction regardless of the state of activation. These results again demonstrate that in our experimental system, there are molecules which are unique to either the detergent-soluble or the detergent-insoluble cytoskeletal fraction. Similar studies on Fyn and ZAP-70 protein tyrosine kinases did not disclose significant levels of detergent-insoluble bands, at least within the time frame utilized for Lck. Although the functional significance of the two Lck forms is not yet understood, the transient activation-dependent kinetics of Lck-cytoskeleton association strengthen the claim that each of the two TCR populations may initiate distinct cellular signaling cascades, and suggest that additional signaling molecules may be involved in mediating these functions.


Fig. 5. Lck exhibits changes in detergent-insolubility and apparent molecular weight following TCR-mediated activation. Mouse splenocytes were activated with 2C11 ascites (1:250) for the indicated times after resting overnight, and lysed with MES lysis buffer. Samples (2.5 × 107 cells) were separated to detergent-soluble (SOL) and insoluble (INS) fractions, reduced, and subjected to 8% SDS-PAGE. After transfer to nitrocellulose filters, detection of Lck was achieved by incubation with polyclonal anti-Lck antibodies, protein A-horseradish peroxidase, and enhanced chemiluminescence.
[View Larger Version of this Image (24K GIF file)]


DISCUSSION

In the current study we demonstrate that non-activated T cells express two TCR forms on the cell surface. While one receptor form is localized to the Triton-insoluble fraction and is associated with the cytoskeleton via the zeta  chain, the other is Triton-soluble with no anchorage to the cytoskeleton. Our study focuses on the differences between these two receptor forms and on the inter-relation between the CD3 subunits and the zeta  chain within the cytoskeleton-associated receptors. In addition, we assess the potential physiologic significance of these interactions in normal mouse lymphocytes, by comparing the activation-dependent kinetics of phosphorylation and ubiquitination of the Triton-soluble and Triton-insoluble cska-zeta forms.

Although previous studies described the localization of the TCR to detergent-insoluble cytoskeletal fractions of cell lysates (40, 41), little data was available pertaining to the nature of such associations. Cumulative evidence suggests that the association of the TCR zeta  chain with the cytoskeleton is mediated via the actin microfilaments: 1) whereas interactions with microtubules are temperature sensitive, the zeta -cytoskeleton association is insensitive to a range of temperatures.2 2) Our previous results (13) describe the loss of Triton-insoluble zeta  chain following treatment of cells with the actin microfilament depolymerizing agent cytochalasin B; a recent study by Rozdzial et al. (14) confirmed our results using cytochalasin D, and also showed that zeta  chain and actin can be co-immunoprecipitated under certain conditions. 3) As shown in the current study, DNase I, which is also an actin depolymerizing agent (37), dissociates the TCR zeta  chain from the Triton-insoluble pellet in vitro.

A crucial issue concerning the physiologic importance of cska-zeta in non-activated T cells is whether it associates with the TCR complex on the cell surface or is independently expressed. Although the cytoskeletal localization of the CD3 subunits (Fig. 1A) hinted that cska-zeta chain likely interacts with the TCR complex, previous studies have shown that in T cells, the zeta  chain is not necessarily limited to the TCR, but can exist as part of other receptor complexes with different functions. For example, it was recently shown that zeta  chain physically associates with the transferrin receptor and undergoes phosphorylation upon activation via this receptor (42). Moreover, it has been shown that the cell surface expressed TCR zeta  chain undergoes internalization and recycling independently of the other TCR subunits (43). By co-immunoprecipitation analysis of the zeta  chain in the Triton-insoluble fraction, we provide strong evidence that the cska-zeta chain is associated with the rest of the TCR subunits (Fig. 1B). These results indicate that there are two cell-surface expressed TCR complexes: one is linked to the cytoskeleton while the other is devoid of such an association.

Our analysis of zeta -deficient 5.8 cells together with transfections which reconstitute zeta  chain expression in these cells provides compelling evidence that maximal CD3 detergent insolubility is likely due to the bridging of CD3 to the cytoskeleton via zeta  chain. From this analysis (Table I), it appears that the assembly of cska-zeta with the CD3 subunits is crucial for their detergent insolubility. Moreover, since cska-zeta chain links the CD3 subunits to the cytoskeleton and the CD3 subunits display a hierarchy of localization to the Triton-insoluble cytoskeletal fraction, it is possible that the degree of CD3 cytoskeletal localization reflects the degree of their interaction with the cska-zeta chain. Several models have been suggested depicting the interactions between the receptor subunits (44), but in each case the zeta  chain was arbitrarily placed. Since the I/S ratio follows the pattern: zeta >delta >gamma >> epsilon , our data suggests that the association between cska-zeta and the CD3 subunits may be mediated primarily via the gamma  and delta  chains, in the cytoskeleton-linked receptor population. However, a fuller understanding of the complex interactions between the various receptor subunits awaits a more detailed study. These results suggest that the cska-zeta chain is the main distinguishing feature between these two receptor populations.

It is not known whether there are differences between the two TCR zeta  forms which might account for their differential interactions with the cytoskeleton or alternatively, result from such interactions. A difference in the amino acid sequence of the two zeta  forms was excluded since zeta  chain is localized to both Triton-soluble and Triton-insoluble fractions following transfection of wild type zeta  cDNA to zeta -deficient cells. In addition, several monoclonal and polyclonal antibodies directed at different epitopes recognize both zeta  forms. Another possibility is that cska-zeta chain appears in a different conformation than the soluble zeta  chain. Indeed, our studies utilizing two different labeling techniques (Fig. 2, A-D) revealed that following biotinylation both cska-zeta and soluble zeta  chains are expressed on the cell surface, but are differentially labeled by iodination. These results suggest that either a difference in zeta  chain conformation or occlusion of the tyrosine residue due to steric interference by neighboring subunits could result in poor iodination of the detergent-soluble zeta  chain. Alternatively, association with the cytoskeleton could lead to enhanced exposure of the only tyrosine residue localized to the interface between the transmembrane and extracellular domains. An example of such changes in receptor conformation induced by association with the cytoskeleton comes from a recent report by Gronowski and Bertics (17). Their study shows that a cytoskeleton-associated epidermal growth factor receptor population binds its ligand with a greater affinity than the soluble receptor counterparts, suggesting that this enhanced affinity could result from changes in receptor conformation.

A clue to the putative differential function of the two zeta  forms in non-activated lymphocytes can be derived from our observations demonstrating their differential state of phosphorylation (Fig. 2, E and F). Despite being phosphorylated in non-activated T cells, the cska-zeta chain maintains an apparent molecular mass of 16 kDa, while its soluble 16-kDa counterpart is non-phosphorylated. Furthermore, the soluble fraction of freshly isolated thymocytes and splenocytes often contains a 21-kDa phosphorylated zeta  form (typical of activated T cells and indicative of basal activation in vivo) which is not observed in the Triton-insoluble cytoskeletal fraction. The dissimilarity in the apparent molecular masses of the two phosphorylated zeta  forms could result from variations in the number of phosphorylated tyrosine residues and/or from differences in the site of phosphorylation. The unique phosphorylated cska-zeta form could mediate signaling pathways different from those mediated by the 21-kDa soluble phosphorylated zeta  form.

Much effort has been made to elucidate the function of receptor-cytoskeleton associations (reviewed in Ref. 15). In this study, we provide evidence that the two receptor populations may well mediate different intracellular signaling cascades leading to distinct cellular effects. We have shown that the activation-dependent ubiquitination of zeta  chain, which was previously reported by Cenciarelli et al. (39), is common to both TCR populations. However, there are definite differences in the kinetics of this modification (Fig. 4A). The functional significance of these differential kinetics may be difficult to assess; a recent study by Hou et al. (45) did not observe any changes in the half-life of zeta  chain in cells stably transfected with a mutated zeta  chain which is unable to undergo ubiquitination. However, the role of the differential kinetics of ubiquitination in the soluble and cytoskeletal fractions awaits a systematic study in normal lymphocytes.

One of our more intriguing observations is that the two major phosphorylated zeta  forms, the 21-kDa soluble form and 16-kDa cska-zeta form, each remain in their respective fractions even following 30 min (Fig. 3) and 50 min (data not shown) of stimulation. This dichotomy is maintained despite various activation-dependent modifications, including enhancement of the soluble 21-kDa phosphorylated form. The mode of phosphorylation of each of these zeta  forms could be of major importance in determining their function. For example, while ZAP-70 has been shown to utilize its tandem SH2 domains in a cooperative interaction to bind to paired phosphorylated tyrosine residues in the intracellular region of zeta  chain (46), Fyn has been shown to bind to the first zeta -immune receptor tyrosine-based activation motif when it contains a single phosphorylated tyrosine residue (47). Since the Triton-soluble phosphorylated 21-kDa zeta  chain apparently differs in its phosphorylation pattern from that of the cska-zeta chain, there could be important differences between the two zeta  forms in the binding to ZAP-70, Fyn, and other intracellular signaling molecules.

A recent report by Rozdzial et al. (14) is in agreement with our earlier findings showing that resting lymphocytes contain levels of cska-zeta . Moreover, both their study and our current work show that there is an activation-dependent translocation of zeta  chain to the cytoskeleton. However, our study clearly shows that while the level of phosphorylated soluble 21-kDa zeta  chain increases after 5-30 min of stimulation, no parallel increase is observed in the level of 16-kDa phosphorylated cska-zeta form. This contrasts with the above mentioned study (14) which claims that the level of phosphorylation of cska-zeta is greatly enhanced upon activation. How can these results be reconciled? One possibility is that the stimulation of T cell hybridomas transfected with zeta -chimeric molecules induces a different phosphorylation pattern from the one we observed using normal mouse splenocytes. Another possibility relates to the type of analysis utilized: by non-reducing/reducing two-dimensional SDS-PAGE, we were able to differentiate between the various zeta  forms, including the soluble 21-kDa phosphorylated form, the 16-kDa phosphorylated cska-zeta form, and the phosphorylated ubiquitinated forms. Since analysis in non-reducing one-dimensional SDS-PAGE is less informative, the authors (14) may have observed the sum total of all the insoluble phosphorylated forms: the 16-kDa form which does not increase, and the 24-kDa phosphorylated ubiquitinated form which we find is enhanced upon TCR-stimulation (Fig. 4B), particularly in the cytoskeletal fraction (Fig. 4B).

Our results, which provide information regarding the kinetics and mode of phosphorylation of cska-zeta , suggest a unique function for this form in TCR-mediated activation, possibly by differential interactions with various intracellular signaling molecules. It is possible that the cytoskeleton serves as a matrix for the recruitment and concentration of signaling molecules, which facilitates molecular communications. Indeed, recent studies on platelets (reviewed in Ref. 48) show that various kinases, including those of the src family, are translocated to the cytoskeleton after cell activation. Moreover, a recent study in T cells depicts the translocation of ZAP-70 as well as the Grb2 and PLCgamma 1 molecules to a detergent-insoluble spectrin-enriched fraction subsequent to TCR-mediated activation (49). In our study, we demonstrate that Lck, a key src-family kinase involved in TCR-mediated signaling, also undergoes activation-dependent translocation to the cytoskeleton and a shift in its apparent molecular weight. Ascertaining whether detergent-insoluble Lck binds to cska-zeta remains a priority for future studies, but may necessitate the use of sophisticated cross-linking analysis. Although the role of kinase-cytoskeletal localization is not yet clear, evidence points to significant differences in kinase activity for enzymes linked to the cytoskeleton. For example, it was recently demonstrated that upon receptor ligation, the kinase activity of the cytoskeleton-associated epidermal growth factor receptors is greater than that of the soluble receptors (50). Although no evidence is yet available concerning the putative function of the 60-kDa detergent-insoluble Lck form (present in non-activated and activated T cells), there is a possibility that this form may also possess enhanced kinase activity and play a role in the phosphorylation of cska-zeta .

What is the role of cska-zeta and the cytoskeleton-linked TCR? From our results, it is tempting to speculate that the cytoskeleton-linked receptor population could mediate distinct intracellular signaling cascades. If the actin-based microfilament system is required for TCR-mediated activation as suggested (51, 52), then it is possible that the 16-kDa phosphorylated cska-zeta form could perhaps maintain the cells in a state of partial activation where they can respond swiftly to stimulation, either by their ability to sequester phosphorylation-dependent associated kinases, or by undergoing additional phosphorylation and translocation to the soluble fraction as a 21-kDa phosphorylated zeta  form. However, a study by DeBell et al. (53) suggests that the cytoskeleton could play a role in curbing TCR-mediated signaling events. The 16-kDa phosphorylated cska-zeta form and its associated TCR subunits might negatively regulate TCR-mediated signaling as observed in anergy. Recent studies (54, 55) discuss the potential significance of the 18- and 21-kDa phosphorylated zeta  forms in the detergent-soluble fraction, and the possibility that the ratio of these forms plays a role in binding different kinases and determining whether receptor ligation ultimately culminates in activation or anergy. Although the role of cska-zeta and its putative relation to anergy was beyond the scope of this work, such studies may eventually shed light on the function of the phosphorylated 16-kDa cska-zeta form. Additional studies will be required to discern the roles of the various phosphorylated zeta  forms associated with the two TCR populations in igniting or braking the molecular machinery involved in TCR-mediated signal transduction.


FOOTNOTES

*   This work was supported by the Concern Foundation of Los Angeles and by the United States-Israel Binational Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: The Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel. Tel.: 972-2-757461; Fax: 972-2-424653.
1   The abbreviations used are: TCR, T cell antigen receptor; PAGE, polyacrylamide gel electrophoresis; MES, 4-morpholineethanesulfonic acid.
2   S. Caplan and M. Baniyash, unpublished data.

Acknowledgments

We thank Larry Samelson, Stu Frank, and Francois Letourneur for their generous provision of the FLzeta and Tzeta zeta cDNA constructs. We are especially grateful to Avery Ben Zeev for his expertise. We also thank Benjamin Rivnay, Aubrey Caplan, Eitan Yefenof, and Larry Samelson for the critical reading of this manuscript. We gratefully acknowledge the support of the Society for Research Associates of the Lautenberg Center.


REFERENCES

  1. Weiss, A., Littman, D. (1994) Cell 76, 263-274 [CrossRef][Medline] [Order article via Infotrieve]
  2. Rudd, C. E., Janssen, O., Yun-Cai, C., da Silva, A. J., Raab, M., Prasad, K. V. S. (1994) Immunol. Today 15, 225-234 [CrossRef][Medline] [Order article via Infotrieve]
  3. Samelson, L. E., Patel, M. D., Weissman, A. M., Harford, J. B., Klausner, R. D. (1986) Cell 46, 1083-1090 [CrossRef][Medline] [Order article via Infotrieve]
  4. Baniyash, M., Garcia-Morales, P., Luong, E., Samelson, L. E., Klausner, R. D. (1988) J. Biol. Chem. 263, 18225-18230 [Abstract/Free Full Text]
  5. Samelson, L. E., Klausner, R. D. (1992) J. Biol. Chem. 267, 24913-24916 [Free Full Text]
  6. Weiss, A. (1993) Cell 73, 209-212 [CrossRef][Medline] [Order article via Infotrieve]
  7. Sarosi, G. A., Thomas, P. M., Egerton, M., Phillips, A. F., Kim, K. W., Bonvini, E., Samelson, L. E. (1992) Int. Immunol. 4, 1211-1217 [Abstract/Free Full Text]
  8. Timson Gauen, L. K., Kong, A. N. T., Samelson, L. E., Shaw, A. S. (1992) Mol. Cell. Biol. 12, 5438-5446 [Abstract/Free Full Text]
  9. Nakayama, T., Singer, A., Hsi, E. D., Samelson, L. E. (1989) Nature 341, 651-654 [CrossRef][Medline] [Order article via Infotrieve]
  10. van Oers, N. S. C., Killeen, N., Weiss, A. (1994) Immunity 1, 675-685 [CrossRef][Medline] [Order article via Infotrieve]
  11. Ravichandran, K. S., Lee, K. K., Songyang, Z., Cantley, L. C., Burn, P., Burakoff, S. J. (1993) Science 262, 902-904 [Abstract/Free Full Text]
  12. Osman, N., Lucas, S. C., Turner, H., Cantrell, D. (1995) J. Biol. Chem. 270, 13981-13986 [Abstract/Free Full Text]
  13. Caplan, S., Zeliger, S., Wang, L., Baniyash, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4768-4772 [Abstract/Free Full Text]
  14. Rozdzial, M. M., Malissen, B., Finkel, T. H. (1995) Immunity 3, 823-833 [CrossRef]
  15. Caplan, S., Baniyash, M. (1995) Immunol. Res. 14, 98-118 [Medline] [Order article via Infotrieve]
  16. den Hartigh, J. C., van Bergen, Henegouwen, P. M. P., Verkleij, A. J., Boonstra, J. (1992) J. Cell Biol. 119, 349-355 [Abstract/Free Full Text]
  17. Gronowski, A. M., Bertics, P. J. (1993) Endocrinology 133, 2838-2846 [Abstract/Free Full Text]
  18. Luna, E. J., Hitt, A. L. (1992) Science 258, 955-963 [Abstract/Free Full Text]
  19. Offringa, R., Bierer, B. E. (1993) J. Biol. Chem. 268, 4979-4988 [Abstract/Free Full Text]
  20. Lokeshwar, V. B., Bourguignon, L. Y. W. (1992) J. Biol. Chem. 287, 21551-21557
  21. Braun, J., Hochman, P. S., Unanue, E. R. (1982) J. Immunol. 128, 1198-1204 [Abstract]
  22. Woda, B. A., McFadden, M. L. (1983) J. Immunol. 131, 1917-1919 [Abstract]
  23. Woda, B. A., Woodin, M. B. (1984) J. Immunol. 133, 2767-2772 [Abstract]
  24. Albrecht, D. L., Noelle, R. J. (1988) J. Immunol. 141, 3915-3922 [Abstract]
  25. Robertson, D., Holowka, D., Baird, B. (1986) J. Immunol. 136, 4565-4572 [Abstract]
  26. Apgar, J. R. (1990) J. Immunol. 145, 3814-3822 [Abstract]
  27. Mao, S. Y., Alber, G., Rivera, J., Kochan, J., Metzger, H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 222-226 [Abstract/Free Full Text]
  28. Hedrick, S. M., Matis, L. A., Hecht, T. T., Samelson, L. E., Longo, D. L., Heber-Katz, E., Schwartz, R. H. (1982) Cell 30, 141-152 [CrossRef][Medline] [Order article via Infotrieve]
  29. Leo, O., Foor, M., Sachs, D. M., Samelson, L. E., Bluestone, J. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1374-1378 [Abstract/Free Full Text]
  30. Samelson, L. E., Weissman, A. M., Robey, F. A., Berkower, I., Klausner (1986) J. Immunol. 137, 3254-3258 [Abstract]
  31. Orloff, D. G., Frank, S. J., Robey, F. A., Weissman, A. M., Klausner, R. D. (1989) J. Biol. Chem. 264, 14812-14817 [Abstract/Free Full Text]
  32. Frank, S. J., Niklinska, B. B., Orloff, D. G., Mercep, M., Ashwell, J. D., Klausner, R. D. (1990) Science 249, 174-177 [Abstract/Free Full Text]
  33. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., Arai, N. (1988) Mol. Cell. Biol. 8, 466-472 [Abstract/Free Full Text]
  34. Letourneur, F., Klausner, R. D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8905-8909 [Abstract/Free Full Text]
  35. Avnur, Z., Small, J. V., Geiger, B. (1983) J. Cell Biol. 96, 1622-1630 [Abstract/Free Full Text]
  36. Hamel, E., Lin, C. N. (1984) Biochemistry 23, 4173-4184 [CrossRef][Medline] [Order article via Infotrieve]
  37. Lelkes, P. I., Friedman, J. E., Rosenheck, K., Oplatka, A. (1986) FEBS Lett. 208, 357-363 [CrossRef][Medline] [Order article via Infotrieve]
  38. Sussman, J. J., Bonifacino, J. S., Lippincott-Schwartz, J., Weissman, A. M., Saito, T., Klausner, R. D., Ashwell, J. D. (1988) Cell 52, 85-95 [CrossRef][Medline] [Order article via Infotrieve]
  39. Cenciarelli, C., Hou, D., Hsu, K.-C., Rellahan, B. L., Wiest, D. L., Smith, H. T., Fried, V. A., Weissman, A. M. (1992) Science 257, 795-7978 [Abstract/Free Full Text]
  40. Marano, N., Holowka, D., Baird, B. (1989) J. Immunol. 143, 931-938 [Abstract]
  41. Geppert, T. D., Lipsky, P. E. (1991) J. Immunol. 146, 3298-3305 [Abstract]
  42. Salmerón, A., Borroto, A., Fresno, M., Crumpton, M. J., Ley, S. C., Alarcón, B. (1995) J. Immunol. 154, 1675-1683 [Abstract]
  43. Ono, S., Ohno, H., Saito, T. (1995) Immunity 2, 639-644 [CrossRef][Medline] [Order article via Infotrieve]
  44. Manolios, N., Kemp, O., Li, Z. G. (1994) Eur. J. Immunol. 24, 84-92 [Medline] [Order article via Infotrieve]
  45. Hou, D., Cenciarelli, C., Jensen, J. P., Nguyen, H. B., Weissman, A. M. (1994) J. Biol. Chem. 269, 14244-14247 [Abstract/Free Full Text]
  46. Isakov, N., Wange, R. L., Burgess, W. H., Watts, J. D., Aebersold, R., Samelson, L. E. (1995) J. Exp. Med. 181, 375-380 [Abstract/Free Full Text]
  47. Osman, N., Lucas, S., Cantrell, D. (1995) Eur. J. Immunol. 25, 2863-2869 [Medline] [Order article via Infotrieve]
  48. Clark, E. A., Shattil, S. J., Brugge, J. S. (1994) Trends Biochem. Sci. 19, 464-469 [CrossRef][Medline] [Order article via Infotrieve]
  49. Nel, A. E., Gupta, S., Lee, L., Ledbetter, J. A., Kanner, S. B. (1995) J. Biol. Chem. 270, 18428-18436 [Abstract/Free Full Text]
  50. Gronowski, A. M., Bertics, P. J. (1995) Endocrinology 136, 2198-2205 [Abstract]
  51. Parsey, M. V., Lewis, G. K. (1993) J. Immunol. 151, 1881-1893 [Abstract]
  52. Valitutti, S., Dessing, M., Aktories, K., Gallati, H., Lanzavecchia, A. (1995) J. Exp. Med. 181, 577-584 [Abstract/Free Full Text]
  53. DeBell, K. E., Conti, A., Alava, M. A., Hoffman, T., Bonvini, E. (1992) J. Immunol. 149, 2271-2280 [Abstract]
  54. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B., Allen, P. M. (1994) Cell 79, 913-922 [CrossRef][Medline] [Order article via Infotrieve]
  55. Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E., Germain, R. N. (1995) Science 267, 515-518 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Sci SignalHome page
R. Varma
TCR Triggering by the pMHC Complex: Valency, Affinity, and Dynamics
Sci. Signal., May 13, 2008; 1(19): pe21 - pe21.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Lysechko and H. L. Ostergaard
Differential Src Family Kinase Activity Requirements for CD3{zeta} Phosphorylation/ZAP70 Recruitment and CD3{epsilon} Phosphorylation
J. Immunol., June 15, 2005; 174(12): 7807 - 7814.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. A Lyubchenko, G. A Wurth, and A. Zweifach
The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing
J. Physiol., March 15, 2003; 547(3): 835 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. G. Garcia and R. A. Miller
Age-Dependent Defects in TCR-Triggered Cytoskeletal Rearrangement in CD4+ T Cells
J. Immunol., November 1, 2002; 169(9): 5021 - 5027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Krishnan, V. G. Warke, M. P. Nambiar, H. K. Wong, G. C. Tsokos, and D. L. Farber
Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3{zeta} expression
Blood, June 15, 2001; 97(12): 3851 - 3859.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Krawczyk and J. M. Penninger
Molecular motors involved in T cell receptor clusterings
J. Leukoc. Biol., March 1, 2001; 69(3): 317 - 330.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C. Arrieumerlou, C. Randriamampita, G. Bismuth, and A. Trautmann
Rac Is Involved in Early TCR Signaling
J. Immunol., September 15, 2000; 165(6): 3182 - 3189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Bronstein-Sitton, L. Wang, L. Cohen, and M. Baniyash
Expression of the T Cell Antigen Receptor zeta Chain following Activation Is Controlled at Distinct Checkpoints. IMPLICATIONS FOR CELL SURFACE RECEPTOR DOWN-MODULATION AND RE-EXPRESSION
J. Biol. Chem., August 13, 1999; 274(33): 23659 - 23665.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Annenkov, S. P. Moyes, Z. Eshhar, R. A. Mageed, and Y. Chernajovsky
Loss of Original Antigenic Specificity in T Cell Hybridomas Transduced with a Chimeric Receptor Containing Single-Chain Fv of an Anti-Collagen Antibody and Fc{epsilon}RI-Signaling {gamma} Subunit
J. Immunol., December 15, 1998; 161(12): 6604 - 6613.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Rozdzial, C. M. Pleiman, J. C. Cambier, and T. H. Finkel3
pp56Lck Mediates TCR {zeta}-Chain Binding to the Microfilament Cytoskeleton
J. Immunol., November 15, 1998; 161(10): 5491 - 5499.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. G. Woodside, D. K. Wooten, and B. W. McIntyre
Adenosine Diphosphate (ADP)-Ribosylation of the Guanosine Triphosphatase (GTPase) Rho in Resting Peripheral Blood Human T Lymphocytes Results in Pseudopodial Extension and the Inhibition of  T Cell Activation
J. Exp. Med., October 5, 1998; 188(7): 1211 - 1221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Berg, L. G. Puente, W. Dawicki, and H. L. Ostergaard
Sustained TCR Signaling Is Required for Mitogen-Activated Protein Kinase Activation and Degranulation by Cytotoxic T Lymphocytes
J. Immunol., September 15, 1998; 161(6): 2919 - 2924.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caplan, S.
Right arrow Articles by Baniyash, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caplan, S.
Right arrow Articles by Baniyash, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement